- Home
- A-Z Publications
- Current Pharmaceutical Design
- Previous Issues
- Volume 14, Issue 8, 2008
Current Pharmaceutical Design - Volume 14, Issue 8, 2008
Volume 14, Issue 8, 2008
-
-
Editorial [ Current Trends in the Treatment of Supraventricular Tachycardia in Pediatric Age Executive Editors: S. Novo and G. Barbaro ]
Authors: Salvatore Novo and Giuseppe BarbaroIn pediatric age supraventricular tachiarrhythmias represent one of the most common cause of admission in cardiology units. Supraventricular arrhythmias may significantly influence the normal growth of a child with significant psycho-social implications. Pediatric cardiologists should be aware about the arrhythmias they face in their clinical practice. Moreover, they should know the possible risks related to specific arrhyth Read More
-
-
-
Supraventricular Tachycardia in Infants: Epidemiology and Clinical Management
Authors: Maria P. Calabro, Marco Cerrito, Francesco Luzza and Giuseppe OretoSupraventricular tachycardias (SVTs) are observed in 0,1-0,4% of the paediatric population and represent an important clinical problem with related significant health and social issues. Most tachycardias are paroxysmal, being associated with sudden onset and termination, and only a relatively small number of them is permanent, namely chronic. Paroxysmal tachycardias, in addition, can be either sustained (lasting > 30 second Read More
-
-
-
Characterization of Supraventricular Tachycardia in Infants: Clinical and Instrumental Diagnosis
Authors: G. Vignati and G. AnnoniSupraventricular tachycardia (SVT) is the most common symptomatic arrhythmias in children. Re-entry tachycardias are the most common form, on the contrary automatic tachycardias are relatively rare. There are four types or re-entry: along anomalous pathway with bi-directional (Wolff-Parkinson-White) or unidirectional conduction, intranodal re-entry, intra-atrial re-entry that is common after surgical procedure, and fina Read More
-
-
-
Supraventricular Tachycardia in Fetus: How Can We Treat ?
Authors: Maurizio Mongiovi and Salvatore PipitoneThe normal fetal cardiac rhythm is characterized by a regular heart rate ranging between 100 and 160 -180 beats/min with a normal 1: 1 atrioventricular electromechanical relationship during each cardiac cycle. Fetal tachycardia occurring in approximately 0.5% of all pregnancies and it is an important cause of fetal morbidity and mortality. A fetal tachycardic heart is at risk for developing low cardiac output, hydrops an Read More
-
-
-
Infants and Children with Tachycardia: Natural History and Drug Administration
Authors: Peter P. Karpawich, Michael D. Pettersen, Pooja Gupta and Nishant ShahTachyarrhythmias can occur at any age from the developing fetus through adulthood. However, in deference to adult-onset ischemic cardiac issues, abnormal heart rhythms occurring in the young are often due to developmental alterations of the cardiac conduction tissue, genetically-inherited changes of myocardial cellular ion membrane properties and both pre- and post-surgical repair of associated structural conge Read More
-
-
-
Pharmacological Therapy in Children with Atrioventricular Reentry: Which Drug?
Authors: Christopher Ratnasamy, Marie Rossique-Gonzalez and Ming-Lon YoungAtrioventricular reentrant tachycardia (AVRT) is the most common cause of supraventricular tachycardia in young children. In nearly 70% of cases, there is manifest preexcitation on electrocardiogram. In the rest, the accessory pathway is concealed. Drugs control AVRT by affecting conduction through the atrioventricular node (beta-blockers, digoxin, verapamil) or accessory pathway (flecainide, propafenone) or both (sotalol, a Read More
-
-
-
Sudden Death and Ventricular Preexcitation: Is it Necessary to Treat the Asymptomatic Patients?
Authors: Carlo Pappone, Andrea Radinovic and Vincenzo SantinelliCurrently, asymptomatic ventricular preexcitation, which has been put at rest for many decades, remains a clinical challenge as there are no predictors of sudden death, which can be the first clinical presentation of the syndrome. Identification of risk factors for sudden death is important, considering the availability of a definitive treatment. Now, as radiofrequency catheter ablation of accessory pathways has reported succ Read More
-
-
-
Pharmacological Therapy in Children with Nodal Reentry Tachycardia: When, How and How Long to Treat the Affected Patients
Authors: R. Bouhouch, T. E. Houari, I. Fellat and M. ArharbiAtrio-ventricular nodal reentrant tachycardia (AVNRT) is a rare supra-ventricular tachycardia (SVT) in children and becomes more frequent in adolescents. Most of children with an AVNRT have a healthy heart thus rarely experiencing severe symptoms. Because of haemodynamic instability or risk of complications, recurrences of SVT may require a chronic therapy. Interruption of dual atrioventricular nodal physiology is the b Read More
-
-
-
Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter
Heart rhythm disorders in children are not different, on electrocardiographic trace, from heart rhythm disorders in adults with the exception of incidence which is different according to the age. Paticularly, atrial flutter (FlA) and fibrillation (FA) are very uncommon arrhythmias in the general pediatric population. Generally atrial fibrillation and atrial flutter, in our experience, is a temporary heart rhythm disturbance connected Read More
-
-
-
Written Consent to Use the Drug in Children: The Problem of Off-Label Drugs
Authors: Gustavo Maid, Marianna Guerchicoff, Mariano Falconi and Diego P. de ArenazaCardiac arrhythmias in pediatric patients have different mechanisms and frequencies compared to adult patients. There are many physiological differences between children and adults that may affect the pharmacodynamic and pharmacokinetic of the antiarrhythmic drugs in pediatric population. Children, and specially breast feeding children, cannot be considered low weighted adults to select antiarrhythmic drug dose Read More
-
-
-
Collateral Effects of Antiarrhythmics in Pediatric Age
By K.M. S. AliAlthough there are numerous reports of antiarrhythmic use in children, controlled, comparison trials of antiarrhythmic agents in children are virtually nonexistent and most data are obtained from case series of children treated. Effective and safe pharmacological therapy requires that the physicians attempt to identify a drug with the most appropriate profile to attack the most vulnerable parameter of the mechanisms of t Read More
-
-
-
Transcatheter Ablation of Supraventricular Tachycardias in Pediatric Patients
Authors: Antonella D. Santis, Giovanni Fazio, Massimo Stefano Silvetti and Fabrizio DragoAblation has become an important treatment for many pediatric patients with common supraventricular tachycardias (SVTs). Many multicenter studies have documented that radiofrequency (RF) catheter ablation is a safe and effective procedure for treatment of a large variety of SVTs in children and adults with a high success rate and minimal complications. Novel electrophysiology technologies such as electroanatomic Read More
-
-
-
Scope and Limitations of The Co-Drug Approach to Topical Drug Delivery
Authors: W. M. Lau, A. W. White, S. J. Gallagher, M. Donaldson, G. McNaughton and C. M. HeardMany currently available drugs show unfavourable physicochemical properties for delivery into or across the skin and temporary chemical modulation of the penetrant is one option to achieve improved delivery properties. Pro-drugs are chemical derivatives of an active drug which is covalently bonded to an inactive pro-moiety in order to overcome pharmaceutical and pharmacokinetic barriers. A pro-drug relies upon Read More
-
-
-
Histone Deacetylase Inhibitors: New Hope for Rheumatoid Arthritis?
Authors: Q. Y. Choo, P. C. Ho and H. S. LinHistone deacetylase (HDAC) inhibitors are a new family of anti-cancer agents currently undergoing clinical investigations for various oncology indications. Their anti-inflammatory activities had been well documented and they appear to be potential therapeutic strategies for various inflammatory diseases. In this review, the anti-inflammatory activities of HDAC inhibitors with emphasis on their potential applications in Read More
-
Volumes & issues
-
Volume 31 (2025)
-
Volume 30 (2024)
-
Volume 29 (2023)
-
Volume 28 (2022)
-
Volume 27 (2021)
-
Volume 26 (2020)
-
Volume 25 (2019)
-
Volume 24 (2018)
-
Volume 23 (2017)
-
Volume 22 (2016)
-
Volume 21 (2015)
-
Volume 20 (2014)
-
Volume 19 (2013)
-
Volume 18 (2012)
-
Volume 17 (2011)
-
Volume 16 (2010)
-
Volume 15 (2009)
-
Volume 14 (2008)
- Issue 36
- Issue 35
- Issue 34
- Issue 33
- Issue 32
- Issue 31
- Issue 30
- Issue 29
- Issue 28
- Issue 27
- Issue 26
- Issue 25
- Issue 24
- Issue 23
- Issue 22
- Issue 21
- Issue 20
- Issue 19
- Issue 18
- Issue 17
- Issue 16
- Issue 15
- Issue 14
- Issue 13
- Issue 12
- Issue 11
- Issue 10
- Issue 9
- Issue 8
- Issue 7
- Issue 6
- Issue 5
- Issue 4
- Issue 3
- Issue 2
- Issue 1
-
Volume 13 (2007)
-
Volume 12 (2006)
-
Volume 11 (2005)
-
Volume 10 (2004)
-
Volume 9 (2003)
-
Volume 8 (2002)
-
Volume 7 (2001)
-
Volume 6 (2000)
Most Read This Month
Article
content/journals/cpd
Journal
10
5
false
en
